TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You” April 8, 1977